المؤلفون: Sánchez-Maldonado, J. M.^{Aff1, Aff2, Aff3}, Campa, D., Springer, J., Badiola, J.^{Aff2, Aff3}, Niazi, Y.^{Aff6, Aff7, Aff8}, Moñiz-Díez, A.^{Aff1, Aff2, Aff3}, Hernández-Mohedo, F.^{Aff2, Aff3}, González-Sierra, P.^{Aff2, Aff3}, Ter Horst, R., Macauda, A.^{Aff4, Aff10}, Brezina, S., Cunha, C.^{Aff12, Aff13}, Lackner, M., López-Nevot, M. A., Fianchi, L., Pagano, L., López-Fernández, E.^{Aff2, Aff3}, Potenza, L., Luppi, M., Moratalla, L.^{Aff2, Aff3}, Rodríguez-Sevilla, J. J., Fonseca, J. E.^{Aff19, Aff20}, Tormo, M., Solano, C., Clavero, E., Romero, A., Li, Y.^{Aff9, Aff22}, Lass-Flörl, C., Einsele, H., Vazquez, L., Loeffler, J., Hemminki, K.^{Aff6, Aff24, Aff25}, Carvalho, A.^{Aff12, Aff13}, Netea, M. G.^{Aff9, Aff26}, Gsur, A., Dumontet, C., Canzian, F., Försti, A.^{Aff6, Aff7, Aff8}, Jurado, M.^{Aff1, Aff2, Aff3}, Sainz, J.^{Aff1, Aff2, Aff3, Aff28, IDs4140802000341y_cor40}

المصدر: Blood Cancer Journal. 10(7)

المؤلفون: Lupiañez, C B, Martínez-Bueno, M, Sánchez-Maldonado, J M, Badiola, J, Cunha, C, Springer, J, Lackner, M, Segura-Catena, J, Canet, L M, Alcazar-Fuoli, L, López-Nevot, M A, Fianchi, L, Aguado, J M, Pagano, L, López-Fernández, E, Alarcón-Riquelme, M, Potenza, L, Gonçalves, S M, Luppi, M, Moratalla, L, Solano, C, Sampedro, A, González-Sierra, P, Cuenca-Estrella, M, Lagrou, K, Maertens, J A, Lass-Flörl, C, Einsele, H, Vazquez, L, PCRAGA Study Group, Loeffler, J, Ríos-Tamayo, R, Carvalho, A, Jurado, M, Sainz, J

المصدر: INFECTION AND IMMUNITY
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname

مصطلحات موضوعية: 0301 basic medicine, host immunity, Genotype, 030106 microbiology, Immunology, Population, CX3C Chemokine Receptor 1, Single-nucleotide polymorphism, ARNT2, CX3CR1, genetic susceptibility, invasive aspergillosis, Biology, Aspergillosis, Microbiology, Polymorphism, Single Nucleotide, Risk Assessment, 03 medical and health sciences, medicine, Genetic predisposition, Basic Helix-Loop-Helix Transcription Factors, Humans, Genetic Predisposition to Disease, Allele, education, Invasive Pulmonary Aspergillosis, education.field_of_study, Haplotype, Aryl Hydrocarbon Receptor Nuclear Translocator, PCRAGA Study Group, medicine.disease, Hematologic Diseases, 3. Good health, Settore MED/15 - MALATTIE DEL SANGUE, 030104 developmental biology, Infectious Diseases, Aspergillus, Case-Control Studies, Expression quantitative trait loci, Parasitology

وصف الملف: Electronic-Print

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f43290f6aa91b179dcb728a0944b95f
https://hdl.handle.net/10668/14981

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Lupiañez, C. B., Martínez-Bueno, M., Sánchez-Maldonado, J. M., Badiola, J., Cunha, C., Springer, J., Lackner, M., Segura-Catena, J., Canet, L. M., Alcazar-Fuoli, L., López-Nevot, M. A., Fianchi, L., Aguado, J. M., Pagano, L., López-Fernández, E., Alarcón-Riquelme, M., Potenza, L., Gonçalves, S. M., Luppi, M., Moratalla, L., Solano, C., Sampedro, A., González-Sierra, P., Cuenca-Estrella, M., Lagrou, K., Maertens, J. A., Lass-Flörl, C., Einsele, H., Vazquez, L., Loeffler, J., Ríos-Tamayo, R., Carvalho, A., Jurado, M., Sainz, J.

المصدر: Infection and Immunity; March 2020, Vol. 88 Issue: 4

المؤلفون: Lupiañez CB; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.; Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., Martínez-Bueno M; Genomic Medicine Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain., Sánchez-Maldonado JM; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., Badiola J; Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., Cunha C; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's, PT Government Associate Laboratory, Braga, Portugal., Springer J; Universitätsklinikum Würzburg, Medizinische Klinik II, Würzburg, Germany., Lackner M; Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria., Segura-Catena J; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.; Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., Canet LM; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., Alcazar-Fuoli L; Mycology Reference Laboratory, Centro Nacional de Microbiologia, Instituto de Salud Carlos III, Madrid, Spain., López-Nevot MA; Immunology Department, Virgen de las Nieves University Hospital, Granada, Spain., Fianchi L; Istituto di Ematologia, Università Cattolica del S. Cuore, Rome, Italy., Aguado JM; Unit of Infectious Diseases, Hospital Universitario '12 de Octubre,' Instituto de Investigación Hospital '12 de Octubre' (i+12), Madrid, Spain., Pagano L; Istituto di Ematologia, Università Cattolica del S. Cuore, Rome, Italy., López-Fernández E; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.; Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., Alarcón-Riquelme M; Genomic Medicine Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain., Potenza L; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Policlinico, Modena, Italy., Gonçalves SM; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's, PT Government Associate Laboratory, Braga, Portugal., Luppi M; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Policlinico, Modena, Italy., Moratalla L; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.; Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., Solano C; Hematology Department, Hospital Clinico Universitario-INCLIVA, University of Valencia, Spain., Sampedro A; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.; Department of Microbiology, Virgen de las Nieves University Hospital, Granada, Spain., González-Sierra P; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.; Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., Cuenca-Estrella M; Mycology Reference Laboratory, Centro Nacional de Microbiologia, Instituto de Salud Carlos III, Madrid, Spain., Lagrou K; Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.; Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium.; National Reference Center for Medical Mycology, University Hospitals Leuven, Leuven, Belgium., Maertens JA; Department of Hematology, University Hospitals Leuven, Leuven, Belgium., Lass-Flörl C; Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria., Einsele H; Universitätsklinikum Würzburg, Medizinische Klinik II, Würzburg, Germany., Vazquez L; Hematology Department, University Hospital of Salamanca, Salamanca, Spain., Loeffler J; Universitätsklinikum Würzburg, Medizinische Klinik II, Würzburg, Germany., Ríos-Tamayo R; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.; Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., Carvalho A; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's, PT Government Associate Laboratory, Braga, Portugal., Jurado M; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.; Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., Sainz J; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain juan.sainz@genyo.es.; Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.

مؤلفون مشاركون: PCRAGA Study Group

المصدر: Infection and immunity [Infect Immun] 2020 Mar 23; Vol. 88 (4). Date of Electronic Publication: 2020 Mar 23 (Print Publication: 2020).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0246127 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1098-5522 (Electronic) Linking ISSN: 00199567 NLM ISO Abbreviation: Infect Immun Subsets: MEDLINE

مواضيع طبية MeSH: Genetic Predisposition to Disease* , Polymorphism, Single Nucleotide*, Aryl Hydrocarbon Receptor Nuclear Translocator/*genetics , Aspergillus/*immunology , Basic Helix-Loop-Helix Transcription Factors/*genetics , CX3C Chemokine Receptor 1/*genetics , Invasive Pulmonary Aspergillosis/*genetics, Case-Control Studies ; Genotype ; Hematologic Diseases/complications ; Humans ; Risk Assessment